1. Synthesis and in vitro evaluation of 99mTc radiolabeled lapatinib (LPT) and its PLGA formulation
   Sevki Goksun Gokulu et al, 2024, Journal of Radioanalytical and Nuclear Chemistry CrossRef
2. Endocrine therapy plus HER2-targeted therapy, another favorable option for HR+/HER2+ advanced breast cancer patients
   Yuehua Liang et al, 2024, Therapeutic Advances in Medical Oncology CrossRef
3. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
   S.-A. Im et al, 2023, ESMO Open CrossRef
4. Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine
   İzzet Doğan et al, 2023, European Journal of Breast Health CrossRef
5. Real-World Study: A Powerful Tool for Malignant Tumor Research in General Surgery
   Liang Zhang et al, 2022, Cancers CrossRef